235 related articles for article (PubMed ID: 8338942)
21. Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro--its implication in the pathogenesis of adult T cell leukemia (ATL).
Maeda M
Hum Cell; 1992 Mar; 5(1):70-8. PubMed ID: 1419953
[TBL] [Abstract][Full Text] [Related]
22. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.
Kubota R; Umehara F; Izumo S; Ijichi S; Matsumuro K; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
J Neuroimmunol; 1994 Aug; 53(1):23-9. PubMed ID: 7914211
[TBL] [Abstract][Full Text] [Related]
23. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.
Feuer G; Stewart SA; Baird SM; Lee F; Feuer R; Chen IS
J Virol; 1995 Feb; 69(2):1328-33. PubMed ID: 7815516
[TBL] [Abstract][Full Text] [Related]
24. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia.
Kinoshita T; Tsujimoto A; Shimotohno K
Int J Cancer; 1991 Feb; 47(4):491-5. PubMed ID: 1995478
[TBL] [Abstract][Full Text] [Related]
25. Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.
Kagami Y; Tobinai K; Kinoshita T; Nagai H; Hotta T; Seto M; Ueda R; Saito H
Jpn J Cancer Res; 1993 Apr; 84(4):371-8. PubMed ID: 8390425
[TBL] [Abstract][Full Text] [Related]
26. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.
Satou Y; Yasunaga J; Zhao T; Yoshida M; Miyazato P; Takai K; Shimizu K; Ohshima K; Green PL; Ohkura N; Yamaguchi T; Ono M; Sakaguchi S; Matsuoka M
PLoS Pathog; 2011 Feb; 7(2):e1001274. PubMed ID: 21347344
[TBL] [Abstract][Full Text] [Related]
27. Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Shimamoto Y; Kobayashi M; Miyamoto Y
Leuk Lymphoma; 1996 Jan; 20(3-4):207-15. PubMed ID: 8624458
[TBL] [Abstract][Full Text] [Related]
28. Two major subgroups of human T-cell leukemia virus-1 in Japan.
Siomi H; Nosaka T; Saida T; Miwa H; Hinuma Y; Shirakawa S; Miyamoto N; Kondo T; Araki K; Ichimaru M
Virus Genes; 1988 Jul; 1(4):377-83. PubMed ID: 3265821
[TBL] [Abstract][Full Text] [Related]
29. ATL and HTLV-I: in vivo cell growth of ATL cells.
Uchiyama T
J Clin Immunol; 1996 Nov; 16(6):305-14. PubMed ID: 8946274
[TBL] [Abstract][Full Text] [Related]
30. Human T-lymphotropic virus type I in Japan.
Yamaguchi K
Lancet; 1994 Jan; 343(8891):213-6. PubMed ID: 7904671
[TBL] [Abstract][Full Text] [Related]
31. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.
Ishiguro N; Abe M; Seto K; Sakurai H; Ikeda H; Wakisaka A; Togashi T; Tateno M; Yoshiki T
J Exp Med; 1992 Oct; 176(4):981-9. PubMed ID: 1402668
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
33. Human T-cell-leukemia virus type I in post-transfusional spastic paraparesis: complete proviral sequence from uncultured blood cells.
Bazarbachi A; Huang M; Gessain A; Saal F; Saib A; Peries J; De Thé H; Galibert F
Int J Cancer; 1995 Nov; 63(4):494-9. PubMed ID: 7591256
[TBL] [Abstract][Full Text] [Related]
34. HTLV-1 intragenic viral enhancer influences immortalization phenotype
Maksimova V; Smith S; Seth J; Phelps C; Niewiesk S; Satou Y; Green PL; Panfil AR
Front Immunol; 2022; 13():954077. PubMed ID: 35958554
[TBL] [Abstract][Full Text] [Related]
35. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.
Yasunaga Ji ; Sakai T; Nosaka K; Etoh Ki ; Tamiya S; Koga S; Mita S; Uchino M; Mitsuya H; Matsuoka M
Blood; 2001 May; 97(10):3177-83. PubMed ID: 11342446
[TBL] [Abstract][Full Text] [Related]
36. Essential Role of Human T Cell Leukemia Virus Type 1
Galli V; Nixon CC; Strbo N; Artesi M; de Castro-Amarante MF; McKinnon K; Fujikawa D; Omsland M; Washington-Parks R; Romero L; Caruso B; Durkin K; Brown S; Karim B; Vaccari M; Jacobson S; Zack JA; Van den Broeke A; Pise-Masison C; Franchini G
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315992
[TBL] [Abstract][Full Text] [Related]
37. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells.
Kannagi M; Matsushita S; Harada S
Int J Cancer; 1993 Jun; 54(4):582-8. PubMed ID: 8514449
[TBL] [Abstract][Full Text] [Related]
38. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
39. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
40. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.
Miyazato P; Yasunaga J; Taniguchi Y; Koyanagi Y; Mitsuya H; Matsuoka M
J Virol; 2006 Nov; 80(21):10683-91. PubMed ID: 16943297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
